Natalia Wegner

Senior Associate

Carpmaels & Ransford

Natalia specialises in complex biotechnological subject matter, in particular cell and gene therapies, nucleic acid technologies, antibody-based drugs and engineered therapeutic proteins. She handles mainly European prosecution and opposition cases that require a coordinated strategic approach and often involve multiple parties and associated ongoing or looming disputes. Natalia has particular experience obtaining and defending key patents in relation to commercially valuable products and technologies, as well as advising on and attacking competitors’ IP. A large part of Natalia’s work also involves advising on SPCs, and she has been closely involved in high profile SPC litigation nationally and at the CJEU.

Xuefang Wu

Associate Director, Digital Strategy

Takeda

Yiorgos Christakis

Senior Data Scientist, Early Clinical Development

Pfizer

Vinod Das

Associate Director

Bayer

Tina Morrison

Director, Office of Regulatory Science and Innovation

FDA

Subha Madhavan

Vice President & Head of Clinical AI / ML

Pfizer

Peter Mesenbrink

Executive Director Statistician

Novartis

Murthy Devarakonda

Executive Director and Head of NLP, AI Innovation Center

Novartis

Michael Dandrea

Principal Data Scientist

Genentech

Gabriel Eichler

Vice President of Data, Data 42

Novartis

Ech